Skip to search formSkip to main contentSkip to account menu

rolapitant

Known as: 1,7-diazaspiro(4.5)decan-2-one, 8-(((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-, (5S,8S)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Polysorbate 80 is a synthetic nonionic surfactant used as an excipient in drug formulation. Various products formulated with… 
2017
2017
Rolapitant, a selective and long‐acting neurokinin‐1 receptor antagonist, is approved in an oral formulation for the prevention… 
Highly Cited
2016
Highly Cited
2016
Rolapitant, a novel neurokinin‐1 receptor antagonist, provided effective protection against chemotherapy‐induced nausea and… 
Review
2015
Review
2015
The prevention of chemotherapy-induced nausea and vomiting (CINV) has been revolutionized over the past 25 years. Guideline-based… 
Highly Cited
2015
Highly Cited
2015
PurposeRolapitant is a novel, long-acting neurokinin-1 (NK-1) receptor antagonist. This study evaluated the safety and efficacy… 
Review
2015
Review
2015
The incidence of nausea and vomiting after radiotherapy is often underestimated by physicians, though some 50–80% of patients may… 
2014
2014
e20690 Background: Rolapitant is a potent, highly selective, competitive and long acting NK-1 receptor antagonist in development… 
Highly Cited
2011
Highly Cited
2011
BACKGROUND:Postoperative nausea and vomiting (PONV) are common complications after surgery. Neurokinin-1 (NK1) receptor…